Funds holding NovaBridge Biosciences
ISIN US44975P1030 · Cayman Islands · LEI 549300L1A5T19703RR64
- Fund holders
- 13
- Of which ETFs
- 6 7 other funds
- Value held
- 2.2M $
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| iShares Biotechnology ETF iShares Trust | 591,381 | 1.2M $ | 0.01 % | as of Jun 30, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio Emerging Markets ETF SPDR INDEX SHARES FUNDS | 297,847 | 580.8K $ | 0.00 % | as of Jun 30, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 68,849 | 126.7K $ | 0.00 % | as of May 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Emerging Markets Small Cap ETF SPDR INDEX SHARES FUNDS | 48,319 | 94.2K $ | 0.01 % | as of Jun 30, 2026 ↗ |
| World ex U.S. Core Equity Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 26,330 | 42.1K $ | 0.00 % | as of Jul 31, 2026 ↗ |
| Invesco NASDAQ Future Gen 200 ETF Invesco Exchange-Traded Fund Trust II | 23,427 | 43.1K $ | 0.23 % | as of May 31, 2026 ↗ |
| EMERGING MARKETS CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 20,035 | 32.1K $ | 0.00 % | as of Jul 31, 2026 ↗ |
| Emerging Markets Social Core Equity Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 15,130 | 24.2K $ | 0.00 % | as of Jul 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) China ETF SPDR INDEX SHARES FUNDS | 14,210 | 27.7K $ | 0.01 % | as of Jun 30, 2026 ↗ |
| Emerging Markets Sustainability Core 1 Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 9,306 | 14.9K $ | 0.00 % | as of Jul 31, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 5,925 | 10.9K $ | 0.02 % | as of May 31, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 5,100 | 9.9K $ | 0.00 % | as of Jun 30, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 4,151 | 7.6K $ | 0.01 % | as of May 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Invesco NASDAQ Future Gen 200 ETF Invesco Exchange-Traded Fund Trust II | 0.23 % | as of May 31, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 0.02 % | as of May 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Emerging Markets Small Cap ETF SPDR INDEX SHARES FUNDS | 0.01 % | as of Jun 30, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 0.01 % | as of Jun 30, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 0.01 % | as of May 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) China ETF SPDR INDEX SHARES FUNDS | 0.01 % | as of Jun 30, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio Emerging Markets ETF SPDR INDEX SHARES FUNDS | 0.00 % | as of Jun 30, 2026 ↗ |
| Emerging Markets Social Core Equity Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 0.00 % | as of Jul 31, 2026 ↗ |
| Emerging Markets Sustainability Core 1 Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 0.00 % | as of Jul 31, 2026 ↗ |
| World ex U.S. Core Equity Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 0.00 % | as of Jul 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 13 | -1 | 1,130,010 | -5.5 % |
| 2026Q2 | 14 | +1 | 1,195,329 | -0.1 % |
| 2026Q1 | 13 | +2 | 1,196,592 | +141.5 % |
| 2025Q4 | 11 | +5 | 495,532 | +539.5 % |
| 2025Q3 | 6 | +1 | 77,484 | +24.4 % |
| 2025Q2 | 5 | 0 | 62,267 | -0.8 % |
| 2025Q1 | 5 | 0 | 62,767 | -0.3 % |
| 2024Q4 | 5 | -6 | 62,967 | -71.8 % |
| 2024Q3 | 11 | -2 | 223,502 | -5.4 % |
| 2024Q2 | 13 | -2 | 236,154 | +9.0 % |
| 2024Q1 | 15 | -6 | 216,738 | -82.4 % |
| 2023Q4 | 21 | 1,233,311 |
Institutional managers
47 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 6,032,650 | 14.8M $ | as of Mar 31, 2026 |
| HHLR ADVISORS, LTD. | 5,980,568 | 14.7M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 3,838,198 | 9.4M $ | as of Mar 31, 2026 |
| Siren, L.L.C. | 3,000,000 | 7.4M $ | as of Mar 31, 2026 |
| AIHC Capital Management Ltd | 2,262,933 | 5.6M $ | as of Mar 31, 2026 |
| Point72 Asset Management, L.P. | 1,389,403 | 3.4M $ | as of Mar 31, 2026 |
| Candriam S.C.A. | 1,132,563 | 2.8M $ | as of Mar 31, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,000,000 | 2.5M $ | as of Mar 31, 2026 |
| Woodline Partners LP | 700,000 | 1.7M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 627,496 | 1.5M $ | as of Mar 31, 2026 |
| Exome Asset Management LLC | 576,960 | 1.4M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 370,107 | 910.5K $ | as of Mar 31, 2026 |
| Fiera Capital Corp | 315,681 | 776.6K $ | as of Mar 31, 2026 |
| BARCLAYS PLC | 299,299 | 736.3K $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 272,412 | 670.1K $ | as of Mar 31, 2026 |
| Taikang Asset Management (Hong Kong) Co Ltd | 170,931 | 420.5K $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 166,616 | 409.9K $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 146,322 | 360K $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 112,463 | 276.7K $ | as of Mar 31, 2026 |
| HRT FINANCIAL LP | 107,524 | 264 $ | as of Mar 31, 2026 |
| XTX Topco Ltd | 101,509 | 249.7K $ | as of Mar 31, 2026 |
| AXQ CAPITAL, LP | 83,330 | 205K $ | as of Mar 31, 2026 |
| DYMON ASIA CAPITAL (SINGAPORE) PTE. LTD. | 80,400 | 197.8K $ | as of Mar 31, 2026 |
| Leonteq Securities AG | 80,000 | 196.8K $ | as of Mar 31, 2026 |
| BNP PARIBAS FINANCIAL MARKETS | 73,102 | 179.8K $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Funds holding NovaBridge Biosciences". https://titelia.com/en/stocks/novabridge-biosciences-US44975P1030